We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Creo Medical Group Plc | LSE:CREO | London | Ordinary Share | GB00BZ1BLL44 | ORD GBP0.001 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 34.75 | 34.50 | 35.00 | 34.75 | 34.75 | 34.75 | 216,151 | 08:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Surgical,med Instr,apparatus | 27.17M | -26.94M | -0.0746 | -4.66 | 125.53M |
TIDMCREO
RNS Number : 0800V
Creo Medical Group PLC
18 July 2018
TR-1: Standard form for notification of major holdings
Hot Features
Premium
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer
and to the FCA in Microsoft Word format if possible)(i)
1a. Identity of the issuer or the CREO MEDICAL GROUP PLC
underlying issuer of existing shares
to which voting rights are attached(ii)
:
-----------------------------------------
1b. Please indicate if the issuer is a non-UK issue (please mark
with an "X" if appropriate)
Non-UK issuer
2. Reason for the notification (please mark the appropriate box or
boxes with an "X")
An acquisition or disposal of voting rights X
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rights
Other (please specify)(iii) :
3. Details of person subject to the notification obligation(iv)
Name CANACCORD GENUITY GROUP INC
City and country of registered office VANCOUVER, CANADA
(if applicable)
4. Full name of shareholder(s) (if different from 3.)(v)
Name DISCRETIONARY CLIENTS
-----------------------------------------
City and country of registered office As above
(if applicable)
-----------------------------------------
5. Date on which the threshold was 17 JULY 2018
crossed or reached(vi) :
-----------------------------------------
6. Date on which issuer notified 18 JULY 2018
(DD/MM/YYYY):
-----------------------------------------
7. Total positions of person(s) subject to the notification obligation
% of voting % of voting rights Total of both Total number
rights attached through financial in % (8.A + of voting
to shares instruments 8.B) rights of
(total of (total of 8.B issuer(vii)
8. A) 1 + 8.B 2)
----------------- --------------------- -------------- -----------------
Resulting situation
on the date
on which threshold
was crossed
or reached 16.0685 16.0685 81,123,065
----------------- --------------------- -------------- -----------------
Position of
previous notification
(if
applicable) 15.9500 15.9500
----------------- --------------------- -------------- -----------------
8. Notified details of the resulting situation on the date on which
the threshold was crossed or reached(viii)
A: Voting rights attached to shares
Class/type of Number of voting rights(ix) % of voting rights
shares
ISIN code (if possible)
Direct Indirect Direct Indirect
(Art 9 of (Art 10 of Directive (Art 9 of Directive (Art 10
Directive 2004/109/EC) 2004/109/EC) (DTR5.1) of Directive
2004/109/EC) (DTR5.2.1) 2004/109/EC)
(DTR5.1) (DTR5.2.1)
----------------------
GB00BZ1BLL44 N/A 13,035,269 N/A 16.0685
--------------- ---------------------- ----------------------- --------------
SUBTOTAL 8.
A 13,035,269 16.0685
B 1: Financial Instruments according to Art. 13(1)(a) of Directive
2004/109/EC (DTR5.3.1.1 (a))
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date(x) Conversion Period(xi) rights that may rights
be acquired if
the instrument
is
exercised/converted.
----------- ----------------------------- -------------------------- ------------
SUBTOTAL 8. B 1
----------------------------- -------------------------- ------------
B 2: Financial Instruments with similar economic effect according
to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))
Type of financial Expiration Exercise/ Physical or Number of % of voting
instrument date(x) Conversion cash voting rights rights
Period (xi) settlement(xii)
---------------- ----------------- --------------------- ---------------
SUBTOTAL 8.B.2
--------------------- ---------------
9. Information in relation to the person subject to the notification
obligation (please mark the
applicable box with an "X")
Person subject to the notification obligation is not controlled
by any natural person or legal entity and does not control any
other undertaking(s) holding directly or indirectly an interest
in the (underlying) issuer(xiii)
Full chain of controlled undertakings through which the voting X
rights and/or the
financial instruments are effectively held starting with the
ultimate controlling natural person or legal entity(xiv) (please
add additional rows as necessary)
Name(xv) % of voting rights % of voting rights Total of both
if it equals or through financial if it equals or
is higher than the instruments if it is higher than
notifiable threshold equals or is higher the notifiable
than the notifiable threshold
threshold
---------------------- --------------------- -------------------
Canaccord Genuity
Group Inc. 16.0685 16.0685
---------------------- --------------------- -------------------
Canaccord Genuity
Wealth Group Holdings
Limited 16.0685 16.0685
---------------------- --------------------- -------------------
Canaccord Genuity
Wealth Group Holdings
(Jersey) Limited 16.0685 16.0685
---------------------- --------------------- -------------------
Hargreave Hale
Ltd 16.0685 16.0685
---------------------- --------------------- -------------------
10. In case of proxy voting, please identify:
Name of the proxy holder
------------------------------------------
The number and % of voting rights
held
------------------------------------------
The date until which the voting
rights will be held
------------------------------------------
11. Additional information(xvi)
Place of completion BLACKPOOL, ENGLAND
Date of completion 18 JULY 2018
-------------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
HOLEASXPFLFPEFF
(END) Dow Jones Newswires
July 18, 2018 11:44 ET (15:44 GMT)
1 Year Creo Medical Chart |
1 Month Creo Medical Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
